PHAXIAM Therapeutics SA (DELISTED) (PHXM:DL)
3.10
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
PHAXIAM Therapeutics Market Cap
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| March 11, 2024 | 18.83M |
| March 08, 2024 | 18.83M |
| March 07, 2024 | 18.95M |
| March 06, 2024 | 18.29M |
| March 05, 2024 | 18.29M |
| March 04, 2024 | 15.19M |
| March 01, 2024 | 17.07M |
| February 29, 2024 | 16.65M |
| February 28, 2024 | 16.65M |
| February 27, 2024 | 18.16M |
| February 26, 2024 | 18.16M |
| February 23, 2024 | 17.65M |
| February 22, 2024 | 17.19M |
| February 21, 2024 | 17.19M |
| February 20, 2024 | 23.02M |
| February 16, 2024 | 22.48M |
| February 15, 2024 | 22.48M |
| February 14, 2024 | 22.78M |
| February 13, 2024 | 22.78M |
| February 12, 2024 | 22.78M |
| February 09, 2024 | 24.24M |
| February 08, 2024 | 24.24M |
| February 07, 2024 | 24.24M |
| February 06, 2024 | 24.42M |
| February 05, 2024 | 24.42M |
| Date | Value |
|---|---|
| February 02, 2024 | 24.45M |
| February 01, 2024 | 25.51M |
| January 31, 2024 | 25.58M |
| January 30, 2024 | 25.51M |
| January 29, 2024 | 26.73M |
| January 26, 2024 | 28.07M |
| January 25, 2024 | 26.91M |
| January 24, 2024 | 28.55M |
| January 23, 2024 | 28.86M |
| January 22, 2024 | 31.16M |
| January 19, 2024 | 28.55M |
| January 18, 2024 | 28.55M |
| January 17, 2024 | 31.53M |
| January 16, 2024 | 31.53M |
| January 12, 2024 | 29.16M |
| January 11, 2024 | 28.41M |
| January 10, 2024 | 28.41M |
| January 09, 2024 | 27.94M |
| January 08, 2024 | 32.26M |
| January 05, 2024 | 30.92M |
| January 04, 2024 | 31.04M |
| January 03, 2024 | 31.65M |
| January 02, 2024 | 29.16M |
| December 29, 2023 | 26.97M |
| December 28, 2023 | 28.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.24M
Minimum
Dec 28 2022
240.90M
Maximum
Jan 19 2021
85.82M
Average
76.60M
Median
Mar 19 2020
Market Cap Benchmarks
| DBV Technologies SA | 111.09M |
| Cellectis SA | 220.18M |
| Genfit SA | 187.48M |
| Innate Pharma SA | 204.53M |
| Inventiva SA | 176.15M |
Market Cap Related Metrics
| PE Ratio | 1.031 |
| Price to Book Value | 0.4731 |
| Price | 3.10 |
| Earnings Yield | 96.99% |